Mark Chin, Director at Pyxis Oncology, Inc. (PYXS), bought 1,745,761 shares at $16.00 ($5.0M) on 2021-10-13, disclosed to the SEC on 2021-10-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,433,261 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $2.86 avg | 1,745,761 | $5.0M | 100% |
| Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-17 | $1.2M | — | Filing → |
| HARP | SELL | 2019-12-10 | $10.1M | — | Filing → |